Entrada Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope

Entrada Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

TRDA

organization

SIC: 2834

SEC Insider

$107.9M

540 transactions

Summary

Entrada Therapeutics, Inc. (TRDA) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $90.0MSales: $15.6M41 insiders

Date	Insider	Type	Value
2026-05-04	Sethuraman Natarajan(President, Research & Develop.)	Sell	$399K
2026-05-04	Dowden Nathan J(President & COO)	Sell	$230K
2026-03-03	Doshi Dipal(CEO)	F	$226K
2026-03-03	Dowden Nathan J(President & COO)	F	$165K
2026-03-10	Dowden Nathan J(President & COO)	Sell	$155K
2026-03-10	WENTWORTH KORY JAMES(Chief Financial Officer)	Sell	$148K
2026-03-04	WENTWORTH KORY JAMES(Chief Financial Officer)	Sell	$98K
2026-03-03	WENTWORTH KORY JAMES(Chief Financial Officer)	F	$67K
2026-03-09	WENTWORTH KORY JAMES(Chief Financial Officer)	Sell	$66K
2026-03-09	Dowden Nathan J(President & COO)	Sell	$41K
2026-04-01	WENTWORTH KORY JAMES(Chief Financial Officer)	Sell	$32K
2026-05-20	Zeiher Bernhardt G	Buy	$29K
2026-05-04	Dowden Nathan J(President & COO)	M	$26K
2026-06-10	Zeiher Bernhardt G	A	$0
2026-06-10	Thistle Mary	A	$0
2026-06-10	Chapman Gina	A	$0
2026-06-10	KIM PETER S	A	$0
2026-06-10	PARMAR KUSH	A	$0
2026-06-10	Radhakrishnan Maha	A	$0
2026-05-04	Dowden Nathan J(President & COO)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR